Suvretta Capital Management 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
Suvretta Capital Management disclosed 90 US equity positions worth $3.3bn in its Q3 2025 13F filing. The largest position was ARQT at 6.0% of the reported book, followed by BENITEC BIOPHARMA INC and META. Against the Q2 2025 filing, it opened 7 new positions, added to 18 and reduced 12 among the top 50 holdings.
What did Suvretta Capital Management own in Q3 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | ARQT ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 6.0% | $197.5m | 10,478,000 | -9% | reduced |
| 2 | BENITEC BIOPHARMA INC | 4.2% | $138.6m | 9,876,506 | 0% | held | |
| 3 | META META PLATFORMS INC | Communication Services | 3.8% | $125.6m | 170,973 | 1% | added |
| 4 | LEGN LEGEND BIOTECH CORP | Healthcare | 3.8% | $124.5m | 3,818,009 | 1% | added |
| 5 | 89BIO INC | 3.7% | $121.7m | 8,280,000 | -42% | reduced | |
| 6 | IMTX IMMATICS N.V | Healthcare | 3.1% | $102.5m | 12,030,129 | 0% | held |
| 7 | KO COCA COLA CO | Consumer Defensive | 2.9% | $96.5m | 1,455,080 | 18% | added |
| 8 | GE GE AEROSPACE | Industrials | 2.8% | $93.3m | 310,262 | 0% | held |
| 9 | NVDA NVIDIA CORPORATION | Technology | 2.7% | $90.2m | 483,535 | -3% | reduced |
| 10 | EYPT EYEPOINT PHARMACEUTICALS INC | Healthcare | 2.7% | $88.2m | 6,192,715 | -9% | reduced |
| 11 | BHVN BIOHAVEN LTD | Healthcare | 2.6% | $84.4m | 5,620,271 | 0% | held |
| 12 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 2.5% | $80.9m | 2,132,133 | 22% | added |
| 13 | HD HOME DEPOT INC | Consumer Cyclical | 2.4% | $79.9m | 197,311 | 51% | added |
| 14 | TSM TAIWAN SEMICONDUCTOR MFG LTD | Technology | 2.3% | $77.4m | 277,201 | -8% | reduced |
| 15 | KURA KURA ONCOLOGY INC | Healthcare | 2.2% | $71.8m | 8,116,000 | 0% | held |
| 16 | FERG FERGUSON ENTERPRISES INC | Industrials | 2.1% | $68.8m | 306,260 | 61% | added |
| 17 | AVBP ARRIVENT BIOPHARMA INC | 2.1% | $68.3m | 3,703,452 | 9% | added | |
| 18 | APELLIS PHARMACEUTICALS INC | 2.0% | $65.1m | 2,878,000 | 0% | held | |
| 19 | AMD ADVANCED MICRO DEVICES INC | Technology | 2.0% | $64.5m | 398,799 | 0% | held |
| 20 | ORCL ORACLE CORP | Technology | 1.9% | $63.6m | 226,318 | -2% | reduced |
| 21 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 1.8% | $60.7m | 2,019,000 | -11% | reduced |
| 22 | BAC BANK AMERICA CORP | Financial Services | 1.8% | $59.9m | 1,160,330 | 25% | added |
| 23 | 4XC1 KALVISTA PHARMACEUTICALS INC | 1.8% | $58.1m | 4,768,712 | -4% | reduced | |
| 24 | APO APOLLO GLOBAL MGMT INC | Financial Services | 1.7% | $57.5m | 431,260 | 1% | added |
| 25 | MSFT MICROSOFT CORP | Technology | 1.7% | $56.7m | 109,455 | 11% | added |
| 26 | PALVELLA THERAPEUTICS INC NE | 1.6% | $51.6m | 822,400 | 15% | added | |
| 27 | COF CAPITAL ONE FINL CORP | Financial Services | 1.5% | $50.8m | 238,770 | 23% | added |
| 28 | DHR DANAHER CORPORATION | Healthcare | 1.5% | $50.7m | 255,800 | 46% | added |
| 29 | RCUS ARCUS BIOSCIENCES INC | Healthcare | 1.5% | $50.2m | 3,688,858 | 0% | held |
| 30 | FULC FULCRUM THERAPEUTICS INC | Healthcare | 1.5% | $49.5m | 5,381,000 | 6% | added |
| 31 | CMPX COMPASS THERAPEUTICS INC | 1.5% | $49.4m | 14,101,159 | 97% | added | |
| 32 | AMZN AMAZON COM INC | Consumer Cyclical | 1.5% | $48.0m | 218,547 | -15% | reduced |
| 33 | TSLA TESLA INC | Consumer Cyclical | 1.2% | $40.6m | 91,252 | -1% | reduced |
| 34 | KDP KEURIG DR PEPPER INC | Consumer Defensive | 1.2% | $40.1m | 1,570,000 | – | new |
| 35 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 1.0% | $34.5m | 353,561 | 0% | held |
| 36 | ADVISORSHARES TR | 1.0% | $34.3m | 7,167,000 | – | new | |
| 37 | UNH UNITEDHEALTH GROUP INC | Healthcare | 1.0% | $33.2m | 96,220 | 42% | added |
| 38 | AVIDITY BIOSCIENCES INC | 1.0% | $32.7m | 750,000 | – | new | |
| 39 | ERAS ERASCA INC | Healthcare | 1.0% | $31.6m | 14,502,004 | 0% | held |
| 40 | INSM INSMED INC | Healthcare | 1.0% | $31.4m | 217,783 | -9% | reduced |
| 41 | PROK PROKIDNEY CORP | 0.9% | $29.9m | 12,341,266 | – | new | |
| 42 | CRM SALESFORCE INC | Technology | 0.9% | $29.7m | 125,250 | – | new |
| 43 | DKS DICKS SPORTING GOODS INC | Consumer Cyclical | 0.9% | $28.5m | 128,290 | -51% | reduced |
| 44 | AURA AURA BIOSCIENCES INC | 0.8% | $27.0m | 4,372,884 | 0% | held | |
| 45 | GLUE MONTE ROSA THERAPEUTICS INC | 0.8% | $24.9m | 3,360,000 | 0% | held | |
| 46 | JNJ JOHNSON & JOHNSON | Healthcare | 0.7% | $24.6m | 132,786 | 0% | held |
| 47 | ZURA ZURA BIO LTD | Healthcare | 0.7% | $23.7m | 5,472,891 | 13% | added |
| 48 | BIIB BIOGEN INC | Healthcare | 0.7% | $23.6m | 168,190 | 11% | added |
| 49 | MRVL MARVELL TECHNOLOGY INC | Technology | 0.7% | $22.9m | 272,300 | – | new |
| 50 | NOW SERVICENOW INC | Technology | 0.6% | $20.2m | 22,000 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.